Does Eliquis Cause Internal Bleeding?
Yes, Eliquis (apixaban) can cause internal bleeding. As a direct oral anticoagulant (DOAC) that inhibits factor Xa to prevent blood clots, it increases bleeding risk by slowing clot formation. Internal bleeding includes gastrointestinal bleeds, intracranial hemorrhage, or bleeds into muscles or organs. Clinical trials showed major bleeding in 2.13% of Eliquis users per year versus 3.09% on warfarin, with fatal bleeds at 0.15% versus 0.22%.[1][2]
How Common Is Internal Bleeding on Eliquis?
Major bleeding events occur in about 2-4% of patients annually, depending on dose, age, and conditions like atrial fibrillation or DVT. Gastrointestinal bleeding is most frequent (around 0.8-1.5% per year), followed by intracranial bleeds (0.2-0.6%). Risk rises with higher doses (5mg twice daily vs. 2.5mg), renal impairment, or concurrent antiplatelets like aspirin.[1][3]
What Increases Bleeding Risk with Eliquis?
- Patient factors: Age over 75, low body weight (<60kg), creatinine clearance <30 mL/min, history of bleeding ulcers.
- Drug interactions: Aspirin, clopidogrel, NSAIDs, SSRIs, or other anticoagulants amplify risk.
- Lifestyle: Excessive alcohol, falls, or trauma.
Black box warning on Eliquis label highlights life-threatening, fatal, or intracranial bleeding.[2]
Signs of Internal Bleeding to Watch For
Symptoms include black/tarry stools, vomiting blood, severe headache or dizziness (brain bleed), abdominal pain/swelling, weakness, or unexplained bruising. Seek emergency care immediately—reversal agent andexanet alfa (Andexxa) can neutralize effects within minutes.[2][4]
How Does Eliquis Compare to Other Blood Thinners?
Eliquis has lower intracranial bleeding risk than warfarin (31% relative reduction in ARISTOTLE trial) and similar GI bleed rates to rivaroxaban (Xarelto), but higher than dabigatran in some meta-analyses. No routine monitoring needed unlike warfarin.[1][3]
Can Bleeding Be Reversed or Managed?
Yes—stop Eliquis and use prothrombin complex concentrate (PCC) or andexanet alfa for urgent reversal. Tranexamic acid helps minor bleeds. No specific antidote required for minor cases; renal clearance handles 27% of drug.[2][4]
Who Should Avoid Eliquis Due to Bleeding Risk?
Contraindicated in active pathological bleeding, severe liver disease, or with strong CYP3A4/P-gp inhibitors like ketoconazole. Use caution in recent surgery or spinal procedures.[2]
[1]: ARISTOTLE trial (NEJM 2011) - https://www.nejm.org/doi/full/10.1056/NEJMoa1107039
[2]: Eliquis Prescribing Information (BMS/Pfizer) - https://packageinserts.bms.com/pi/pieliquis.pdf
[3]: Meta-analysis of DOACs (Lancet 2013) - https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)62042-4/fulltext
[4]: Andexxa prescribing info (AstraZeneca) - https://www.accessdata.fda.gov/drugsatfdadocs/label/2018/761028lbl.pdf